IVD China last week: Roche, Siemens Healthineers, Sansure, Dian Diagnostics and Allsheng

Roche Diagnostics Partners with Sanya Yazhou Bay Science and Technology City to Launch Public Innovation Platform for Bioscience Diagnostics

On November 18, Roche Diagnostics China and the Sanya Yazhou Bay Science and Technology City Administration officially announced the completion and launch of the “Sanya Yazhou Bay Science and Technology City Public Innovation Platform for Bioscience Diagnostics.” This initiative leverages policy advantages and integrates international resources to create a comprehensive healthcare ecosystem that links platforms, diagnostics, clinical practice, research, and applications. The platform aims to accelerate the high-level translation of scientific research into practical outcomes, marking a new chapter in Hainan’s healthcare and life sciences sector.

Siemens Healthineers Signs Strategic Agreement with Pengbo (Hong Kong) Neutron Cancer Therapy Center

On November 13, Siemens Healthineers and Pengbo (Hong Kong) Neutron Cancer Therapy Center signed a strategic partnership agreement. This collaboration focuses on deepening cooperation in the field of oncology diagnosis and treatment, with the goal of providing better solutions for cancer patients in China. The partnership leverages each party's expertise and strengths, aiming to explore the future development of boron neutron capture therapy (BNCT) for tumor diagnosis and treatment, bringing the latest global advancements in BNCT to more cancer patients in China.

Sansure Biotech Secures Four CE IVDR Certifications

Recently, Sansure Biotech's independently developed products, including six respiratory pathogen nucleic acid detection kits (PCR-Fluorescent Probe Method), six respiratory bacterial pathogen nucleic acid detection kits (Multiplex Fluorescent PCR Method), Group B Streptococcus nucleic acid detection kit (PCR-Fluorescent Probe Method), and a cell preservation solution, have successfully obtained CE IVDR certification from the European Union.

DIAN Diagnostics Achieves Perfect Score in EuroFlow's External Quality Assessment for Second-generation Flow Cytometry

On November 29, DIAN Diagnostics announced that EuroFlow had released the results of the 2024 Multiple Myeloma Minimal Residual Disease Quality Assessment (MM MRD QA). Competing alongside 50 laboratories worldwide, DIAN Diagnostics achieved a perfect score.

Allsheng Gene Extraction Kits and Genetic Testing Equipment Granted U.S. Patent

Recently, Hangzhou Allsheng Instruments Co., Ltd. was granted a U.S. patent for its invention titled "KIT AND DEVICE FOR USE WITH GENE DETECTION TECHNIQUES AND TESTING", which includes a gene extraction kit and genetic testing equipment.